Latest news
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMTFederal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million - PR NewswirePR Newswire · Mon, 27 Jul 2026 07:00:00 GMT